Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CONy 2020 | Epilepsy treatment outcomes: a 30 year observational study

Martin Brodie • 23 Oct 2020
CONy 2020
Epilepsy

Martin Brodie, MD, University of Glasgow, Glasgow, UK, discusses treating epilepsy. The current anti-seizure drugs target the symptoms of epilepsy, not the root cause. Therefore, not all patients respond to medication. From observing nearly 800 patients over 30 years, data shows that only 60% of patients find relief with a modest dose without side effects. The remaining 40% constitute refractory and relapsing-remitting epilepsy. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.

More from Martin Brodie

Are outcomes of RCTs relevant to treat epilepsy patients or are real-world trials more valuable?
2:57
Are outcomes of RCTs relevant to treat epilepsy patients or are real-world trials more valuable?
Martin Brodie • 23 Mar 2022
The genetics of epilepsy & treatment availability
2:22
The genetics of epilepsy & treatment availability
Martin Brodie • 23 Mar 2022
The need for novel treatments that can modify the development & progression of epilepsy
3:13
The need for novel treatments that can modify the development & progression of epilepsy
Martin Brodie • 23 Mar 2022
The relationship between epilepsy and depression
1:56
The relationship between epilepsy and depression
Martin Brodie • 23 Oct 2020

Related Videos

Which emerging epilepsy therapies are likely to change clinical practice?
9:12
Which emerging epilepsy therapies are likely to change clinical practice?
William Alves Martins • 20 Oct 2026
Phase II/III POWER1: efficacy, safety and lessons learned for vormatrigine in epilepsy
8:05
Phase II/III POWER1: efficacy, safety and lessons learned for vormatrigine in epilepsy
William Alves Martins • 20 Oct 2026
Emerging gene therapies for Dravet syndrome and other DEEs
10:41
Emerging gene therapies for Dravet syndrome and other DEEs
William Alves Martins • 20 Oct 2026
Emerging precision therapies reshaping the antiseizure medication landscape in epilepsy
9:58
Emerging precision therapies reshaping the antiseizure medication landscape in epilepsy
William Alves Martins • 20 Oct 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals